Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Payoux

Showing results (141-150 of 160) with videos related to

Pageof 16
Sort By:
Neuroimage. Clinical|November 21, 2025
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History studyLeonard Pieperhoff, Luigi Lorenzini, Sophie Mastenbroek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History StudyAriane Bollack, Lyduine E Collij, David Vállez García, et al.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
JAMA Neurology|May 8, 2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical TrialDaniele Altomare, Frederik Barkhof, Camilla Caprioglio, et al.
Frontiers in Psychiatry|August 9, 2018
Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)Antoine Yrondi, Bruno Aouizerate, Wissam El-Hage, et al.
Neurology|September 17, 2024
Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without DementiaLuigi Lorenzini, Alessio Maranzano, Silvia Ingala, et al.
Frontiers in Neurology|February 10, 2023
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impactLyduine E Collij, Gill Farrar, David Valléz García, et al.
Neuroimage. Clinical|July 15, 2022
The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflowLuigi Lorenzini, Silvia Ingala, Alle Meije Wink, et al.
Neurobiology of Aging|February 13, 2017
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)Pradeep J Nathan, Yen Ying Lim, Rosemary Abbott, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic ActivityJorge Jovicich, Claudio Babiloni, Clarissa Ferrari, et al.
Pageof 16

Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Neuroimage. Clinical|November 21, 2025
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History studyLeonard Pieperhoff, Luigi Lorenzini, Sophie Mastenbroek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History StudyAriane Bollack, Lyduine E Collij, David Vállez García, et al.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
JAMA Neurology|May 8, 2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical TrialDaniele Altomare, Frederik Barkhof, Camilla Caprioglio, et al.
Frontiers in Psychiatry|August 9, 2018
Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)Antoine Yrondi, Bruno Aouizerate, Wissam El-Hage, et al.
Neurology|September 17, 2024
Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without DementiaLuigi Lorenzini, Alessio Maranzano, Silvia Ingala, et al.
Frontiers in Neurology|February 10, 2023
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impactLyduine E Collij, Gill Farrar, David Valléz García, et al.
Neuroimage. Clinical|July 15, 2022
The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflowLuigi Lorenzini, Silvia Ingala, Alle Meije Wink, et al.
Neurobiology of Aging|February 13, 2017
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)Pradeep J Nathan, Yen Ying Lim, Rosemary Abbott, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic ActivityJorge Jovicich, Claudio Babiloni, Clarissa Ferrari, et al.
Pageof 16